FMCQF (Fresenius Medical Care AG) Piotroski F-Score: 8 (As of Jun. 24, 2026) — 33% Above Median


FMCQF Fresenius Medical Care AG FMCQF
72 GF Score
Price $45.17
GF Value $47.43
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Piotroski F-Score?

Fresenius Medical Care AG FMCQF 72 Piotroski F-Score is 8 as of Jun. 24, 2026, which is 33% above its 10-year median of 6.00. GuruFocus rates FMCQF with a GF Score™ of 72/100 and a GF Value™ of $47.43 (Fairly Valued). The stock has 4 warning signs investors should review. Among 651 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks better than 97.39% on this metric.

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Fresenius Medical Care AG has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Fresenius Medical Care AG's Piotroski F-Score or its related term are showing as below:

FMCQF' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 9
Current: 8

During the past 13 years, the highest Piotroski F-Score of Fresenius Medical Care AG was 9. The lowest was 4. And the median was 6.

Fresenius Medical Care AG  (OTCPK:FMCQF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Fresenius Medical Care AG Piotroski F-Score Related Terms


Fresenius Medical Care AG Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Piotroski F-Score Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 6.00 7.00 7.00 8.00

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 7.00 6.00 8.00 8.00

FMCQF vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Piotroski F-Score falls into.


FMCQF
72GF Score
Fresenius Medical Care AG FMCQF
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 259.827 + 322.532 + 382.995 + 135.872 = $1,101 Mil.
Cash Flow from Operations was 893.806 + 870.374 + 1172.934 + 262.297 = $3,199 Mil.
Revenue was 5526.774 + 5733.392 + 5936.282 + 5331.962 = $22,528 Mil.
Gross Profit was 1400.647 + 1458.002 + 1625.728 + 1363.575 = $5,848 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(35389.226 + 36091.331 + 36252.353 + 36302.498 + 36378.72) / 5 = $36082.8256 Mil.
Total Assets at the begining of this year (Mar25) was $35,389 Mil.
Long-Term Debt & Capital Lease Obligation was $9,989 Mil.
Total Current Assets was $9,373 Mil.
Total Current Liabilities was $7,780 Mil.
Net Income was 201.322 + 236.434 + 70.051 + 163.482 = $671 Mil.

Revenue was 5130.719 + 5283.199 + 5324.384 + 5277.248 = $21,016 Mil.
Gross Profit was 1255.639 + 1272.013 + 1330.291 + 1279.976 = $5,138 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(37321.847 + 36486.545 + 36083.02 + 35148.25 + 35389.226) / 5 = $36085.7776 Mil.
Total Assets at the begining of last year (Mar24) was $37,322 Mil.
Long-Term Debt & Capital Lease Obligation was $10,278 Mil.
Total Current Assets was $8,603 Mil.
Total Current Liabilities was $5,889 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Fresenius Medical Care AG's current Net Income (TTM) was 1,101. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Fresenius Medical Care AG's current Cash Flow from Operations (TTM) was 3,199. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=1101.226/35389.226
=0.03111755

ROA (Last Year)=Net Income/Total Assets (Mar24)
=671.289/37321.847
=0.01798649

Fresenius Medical Care AG's return on assets of this year was 0.03111755. Fresenius Medical Care AG's return on assets of last year was 0.01798649. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Fresenius Medical Care AG's current Net Income (TTM) was 1,101. Fresenius Medical Care AG's current Cash Flow from Operations (TTM) was 3,199. ==> 3,199 > 1,101 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=9989.134/36082.8256
=0.27683902

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=10278.091/36085.7776
=0.28482387

Fresenius Medical Care AG's gearing of this year was 0.27683902. Fresenius Medical Care AG's gearing of last year was 0.28482387. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=9373.356/7779.792
=1.20483375

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=8602.89/5888.503
=1.46096385

Fresenius Medical Care AG's current ratio of this year was 1.20483375. Fresenius Medical Care AG's current ratio of last year was 1.46096385. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Fresenius Medical Care AG's number of shares in issue this year was 275.246. Fresenius Medical Care AG's number of shares in issue last year was 293.413. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=5847.952/22528.41
=0.25958121

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=5137.919/21015.55
=0.24448178

Fresenius Medical Care AG's gross margin of this year was 0.25958121. Fresenius Medical Care AG's gross margin of last year was 0.24448178. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=22528.41/35389.226
=0.63658951

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=21015.55/37321.847
=0.56308976

Fresenius Medical Care AG's asset turnover of this year was 0.63658951. Fresenius Medical Care AG's asset turnover of last year was 0.56308976. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+1+1+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Fresenius Medical Care AG has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 8 mean?
Fresenius Medical Care AG (FMCQF) has a Piotroski F-Score of 8 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Fresenius Medical Care AG and its competitors. This is 33% above median its historical median of 6.00. Over the past decade, Fresenius Medical Care AG's Piotroski F-Score has ranged from 4.00 to 9.00. According to the industry distribution chart, Fresenius Medical Care AG ranks #17 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 2.6%.
Is Fresenius Medical Care AG's Piotroski F-Score too high?
Fresenius Medical Care AG's current Piotroski F-Score of 8 is 33% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Fresenius Medical Care AG's value of 8 is 60% above this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #17 out of 651 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fresenius Medical Care AG has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #17 out of 651 companies for Piotroski F-Score. This places Fresenius Medical Care AG in the top 3% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Fresenius Medical Care AG's value of 8 is 60% above this benchmark. Historically, Fresenius Medical Care AG's own Piotroski F-Score has ranged from 4.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Fresenius Medical Care AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current Piotroski F-Score of 8 is 60% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current Piotroski F-Score is 8, which is 33% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMCQF) is currently considered Fairly Valued. The stock's GF Value™ is $47.43, compared to a current price of $45.17 — trading 4.8% below its estimated fair value. The current Piotroski F-Score is 8, which is 33% above median its 10-year median of 6.00 and 60% above the Healthcare Providers & Services industry median of 5.00. Fresenius Medical Care AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Fresenius Medical Care AG (FMCQF), the current Piotroski F-Score is 8 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (FMCQF) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of $45.17 is trading 4.8% below its estimated GF Value™ of $47.43. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for FMCQF:

  • Piotroski F-Score: 8 (33% above median its 10-year median of 6.00)
  • GF Value™: $47.43 vs. price of $45.17 (4.8% below fair value)
  • GF Score™: 72/100 with 4 warning signs
  • Industry Position: 60% above the Healthcare Providers & Services median (#17 of 651)

No single metric tells the full story. See the FMCQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
72GF Score

Get the complete analysis for FMCQF

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$45.17
Price
$47.43
GF Value